You are here: Home > Clinical Trials & Research > Gastrointestional Cancer
Gastrointestional Cancer
| ACOSOG Z6041 | Lead group: ACOSOG |
| A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for uT2uN0 Rectal Cancer | |
| CALGB 80101 | Lead group: CALGB |
| Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma | |
| E5202 | Lead group: ECOG |
| A Randomized Phase III Study Comparing 5-FU Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers | |
| E5204 | Lead group: ECOG |
| Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation | |
| N0147 | Lead group: NCCTG |
| A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer | |
| NSABP-R-04 | Lead Group: NSABP |
| A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with or without Oxaliplatin with Preoperative Radiation Therapy and Continuous Intravenous Infusion of 5-Fluorouracil with or without Oxaliplatin in the Treatment of Patients with Operable Carcinoma of the Rectum | |
| A6181104 | |
| A randomized, Phase 2b study of sunitinib plus oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) versus bevacizumab plus FOLFOX as first-line treatment in patients with metastatic colorectal cancer. | |
| A4061034 | |
| A Randomized, Phase 2 Study of FOLFOX or FOLFIRI with AG-013736 or Bevacizumab in Patients with Metastatic Colorectal Cancer After Failure of an Irinotecan or Oxaliplatin-Containing First-Line Regimen. | |
We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.
For more information about the clinical trials listed please go to http://www.clinicaltrials.gov/.
Page last updated: 11/12/2008 | Recommend this page | Printer friendly version
